Sharescart Research Club logo
Apollo Green 72 (28.6%)ASK Investment 895 (-3.2%)AVPL 49 (0%)Bootes Impex 775 (-8.8%)CIAL 442 (-0.5%)CSK 254 (-3.1%)ESDS Software 478 (2.8%)Garuda Aerospace 468 (-2.1%)Goodluck Defence 385 (16%)Hero Motors 325 (0%)Hinduja Leyland 248 (0%)ICL Fincorp 25 (0%)Incred Holdings 154 (2.7%)Kineco Limited 3285 (0%)Lava 60 (15.4%)Market Simplified 26 (-7.1%)Matrix Gas 12 (-20%)Motilal Oswal 12.25 (-2%)MSEI 6.35 (-2.3%)NCDEX 368 (-1.6%)NSE 1985 (-2%)Onix Renewable 68 (21.4%)OYO 23 (-4.2%)OYO Assets 9.25 (-7%)Philips India 1250 (0%)Polymatech Electronics 56 (-3.4%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)VCI Chemical 64 (0%)Zepto 40 (-4.8%)

15 Days Price Change

Sat Kartar Life IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 77  to  81 per share
Profile
Min Investment ₹81
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda-based healthcare company dedicated to providing natural wellness solutions through therapeutic and lifestyle products. Focused on promoting a healthier lifestyle, the company offers holistic remedies rooted in traditional Ayurvedic practices, catering directly to individual consumers. Their products are sold through multiple channels, including their own website, third-party e-commerce platforms, television marketing, and social media apps like Google and Meta. Sat Kartar Shopping Limited specializes in two key areas: therapeutic products aimed at addressing specific health issues such as addiction, personal care, and wellness (e.g., Addiction Killer, Liv Muztang), and lifestyle-related products targeting conditions like diabetes, joint pain, piles, and more. The company is also expanding its portfolio to include solutions for additional health concerns, such as slimming, hair care, gut health, PCOD (Polycystic Ovary Disease), and mental wellness. Read More

Basic Info

Face Value 10 per share

Price 77  to  81 per share

P/E (x) 10.9

Sales( Cr.) 163

PAT( Cr.) 10

EPS 7.4

Draft Prospectus --

Exchange NSE-SME

Promoter

Company Promoters

Mr. Manprit Singh Chadha Mr. Pranav Singh Chadha Ms. Simrati Kaur M/s Ajooni Wellness Private Limited.

Pre Issue Share Holding 100%

Post Issue Share Holding 65%

Listing Details:

Listing Price: 169.6

Listing Gain: 52.24%

Current Price: 181

Gain On Issue: 181 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Jan 10, 2025
Closing Date Jan 14, 2025
Allotment Jan 15, 2025
Refund Jan 16, 2025
Delivery of Shares Jan 16, 2025
Listing Date Jan 17, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1600 129,600
Retail (Max) 1 1600 129,600
S-HNI (Min) 2 3200 259,200
S-HNI (Max) 7 11200 907,200
B-HNI (Min) 8 12800 1,036,800

Objective of the Issue

1. To meet the expenses of Unidentified Acquisition (In India or Abroad) 2. To meet the expenses Marketing and Advertisement. 3 .To meet the Capital Expenditure. 4. To meet the expenditure on Investment in Technology 5. To meet out the General Corporate Purposes. 6. To meet out the Issue Expenses.

Issue

Category Nos Bid Bid (x)
QIB 2086400 260278400 124.8x
NII 625920 505931136 808.3x
Retail 1460480 365631168 250.4x
EMP 0 0 0x
Total 4172800 1388624384 332.8x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Sat Kartar Life Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 52 83 128 163
Other Income 0 0 0 1
Total Income 52 83 128 164
Total Expenditure 50 78 118 149
Operating Profit 3 5 10 15
Interest 0 0 1 1
Depreciation 1 1 1 1
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 2 3 9 13
Provision for Tax 0 1 2 3
Profit After Tax 1 3 6 10
Adjustments 0 0 0 0
Profit After Adjustments 1 3 6 10
Adjusted Earnings Per Share 1.2 2.2 5.6 6.2

Sat Kartar Life Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 1 3 9 52
Minority's Interest 0 0 0 0
Borrowings 6 2 1 2
Other Non-Current Liabilities -0 -0 -1 -1
Total Current Liabilities 5 9 12 11
Total Liabilities 12 14 21 64
Fixed Assets 3 4 3 6
Other Non-Current Assets 2 4 7 2
Total Current Assets 7 6 12 56
Total Assets 12 14 21 64

Sat Kartar Life Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 1 1 3
Cash Flow from Operating Activities 2 8 7 -5
Cash Flow from Investing Activities -1 -4 -3 -0
Cash Flow from Financing Activities -1 -5 -3 34
Net Cash Inflow / Outflow 0 -0 2 28
Closing Cash & Cash Equivalent 1 1 3 31

Sat Kartar Life Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 1.24 2.24 5.63 6.23
CEPS(Rs) 1.88 3.41 6.81 7.06
DPS(Rs) 0 0 0.18 0.7
Book NAV/Share(Rs) 0.69 2.92 8.42 32.71
Core EBITDA Margin(%) 4.43 6.26 8.01 8.73
EBIT Margin(%) 3.79 4.73 7.12 8.4
Pre Tax Margin(%) 2.9 4.15 6.72 8.07
PAT Margin (%) 2.67 3.02 4.93 6.02
Cash Profit Margin (%) 4.07 4.61 5.97 6.82
ROA(%) 11.54 19.06 35.5 23
ROE(%) 180.42 123.96 99.24 32.22
ROCE(%) 22.04 49.2 99.92 39.89
Receivable days 0.66 0.4 3.42 9.28
Inventory Days 2.61 1.56 1.28 5.74
Payable days 165.45 185.57 180.64 203.79
PER(x) 0 0 0 24.39
Price/Book(x) 0 0 0 4.65
Dividend Yield(%) 0 0 0 0.46
EV/Net Sales(x) 0.15 0.05 0.02 1.32
EV/Core EBITDA(x) 2.89 0.73 0.2 14.32
Net Sales Growth(%) 0 59.81 54.16 27.37
EBIT Growth(%) 0 99.58 132.34 50.23
PAT Growth(%) 0 80.7 151.6 55.66
EPS Growth(%) 0 80.7 151.6 10.73
Debt/Equity(x) 10.6 1.15 0.19 0.11
Current Ratio(x) 1.27 0.71 1.01 4.92
Quick Ratio(x) 1.2 0.68 0.97 4.52
Interest Cover(x) 4.27 8.2 17.6 25.38
Total Debt/Mcap(x) 0 0 0 0.02

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 27% 46% 0% 0%
Operating Profit CAGR 50% 71% 0% 0%
PAT CAGR 67% 115% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -2% NA% NA% NA%
ROE Average 32% 85% 109% 109%
ROCE Average 40% 63% 53% 53%

Company Contact Information

Sat Kartar Life Ltd.

603, 6th Floor Mercantile House K G Marg

IPO Lead Manager(s)

Sat Kartar Life Ltd.

Narnolia Financial Services Ltd.

Registrar Info

Sat Kartar Life Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp